Table 1.
Demographic, clinical and laboratory findings of subjects (N = 388)
| Characteristic | Value |
|---|---|
| Male gender (%) | 77.8 |
| Age (yrs) | 52.6 ± 12.7 |
| Diabetes, type II (%) | 15.8 |
| GFR (mL/s) | 1.05 ± 0.67 (64 ± 40 ml/min) |
| Systolic blood pressure (mmHg) | 134.3 ± 16.5 |
| Diastolic blood pressure (mmHg) | 80.2 ± 7.8 |
| Pulse pressure (mmHg) | 53.9 ± 15.9 |
| i-PTH (ng/L) | 106.8 ± 126.8 (106.8 ± 126.8 pg/ml) |
| Serum calcium (mmol/L) | 2.37 ± 0.14 (9.52 ± 0.57 mg/dl) |
| Serum calcium (mmol/L) | 2.57 ± 0.14 (10.3 ± 0.57 mg/dl) |
| Serum phosphorus (mmol/L) | 1.26 ± 0.29 (3.90 ± 0.91 mg/dl) |
| Ca × P product (mg2/dl2) | 39.9 ± 8.59 |
| LDL-C (mmol/L) | 3.04 ± 1.10 (117.6 ± 42.6 mg/dl) |
| Homocysteine (μmol/L) | 182.7 ± 169.4 (24.7 ± 22.9 nmol/ml) |
| Fibrinogen (μmol/L) | 10.8 ± 3.3 (367 ± 112.1 mg/dl) |
| HsCRP (mg/L) | 0.49 ± 0.77 |
Data are expressed as mean ± standard deviation. Gender and diabetes mellitus are reported as proportion of population. GFR, glomerular filtration rate; hs-CRP, high-sensitivity C reactive protein; i-PTH, intact parathyroid hormone; LDL-C, low-density lipoprotein-cholesterol; Ca × P, calcium–phosphorus product.